207 related articles for article (PubMed ID: 19875479)
1. Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma.
Lupi I; Manetti L; Caturegli P; Menicagli M; Cosottini M; Iannelli A; Acerbi G; Bevilacqua G; Bogazzi F; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):289-96. PubMed ID: 19875479
[TBL] [Abstract][Full Text] [Related]
2. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
4. Early recognition of aggressive pituitary adenomas: a single-centre experience.
Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
[TBL] [Abstract][Full Text] [Related]
5. The expression profile of PD-L1 and CD8
Wang PF; Wang TJ; Yang YK; Yao K; Li Z; Li YM; Yan CX
J Neurooncol; 2018 Aug; 139(1):89-95. PubMed ID: 29680903
[TBL] [Abstract][Full Text] [Related]
6. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
7. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
Gannage MH; Maacaron C; Okais N; Halaby G
J Med Liban; 1997; 45(2):97-101. PubMed ID: 9289506
[TBL] [Abstract][Full Text] [Related]
9. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.
Lu JQ; Adam B; Jack AS; Lam A; Broad RW; Chik CL
Endocr Pathol; 2015 Sep; 26(3):263-72. PubMed ID: 26187094
[TBL] [Abstract][Full Text] [Related]
11. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
Saeger W; Koch A
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas.
Heshmati HM; Kujas M; Casanova S; Wollan PC; Racadot J; Van Effenterre R; Derome PJ; Turpin G
Endocr J; 1998 Jun; 45(3):357-61. PubMed ID: 9790270
[TBL] [Abstract][Full Text] [Related]
13. Clinical Interrogation for Unveiling an Isolated Hypophysitis Mimicking Pituitary Adenoma.
Lee S; Choi JH; Kim CJ; Kim JH
World Neurosurg; 2017 Mar; 99():735-744. PubMed ID: 27476691
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antipituitary antibodies in acromegaly.
Guaraldi F; Caturegli P; Salvatori R
Pituitary; 2012 Dec; 15(4):490-4. PubMed ID: 22002711
[TBL] [Abstract][Full Text] [Related]
15. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
16. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
Astaf'eva LI; Kadashev BA; Shishkina LV; Kalinin PL; Fomichev DV; Kutin MA; Aref'eva IA; Dzeranova LK; Sidneva YG; Klochkova IS; Rotin DL
Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(6):24-35. PubMed ID: 28139570
[TBL] [Abstract][Full Text] [Related]
17. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
18. Anti-alpha-enolase antibodies in pituitary disease.
Tanaka S; Tatsumi KI; Takano T; Murakami Y; Takao T; Yamakita N; Tahara S; Teramoto A; Hashimoto K; Kato Y; Amino N
Endocr J; 2003 Dec; 50(6):697-702. PubMed ID: 14709840
[TBL] [Abstract][Full Text] [Related]
19. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
